Considering the above-noted findings, our observation that the expression of genes such as LAMB3 and HIF1A increased in EMS patients suggests that early treatment of EMS may be very important to prevent progression to endometrial cancer. The gene discussed is HIF1A; the disease is endometrial cancer.